Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
05/25/2001 | CA2391971A1 Methods and means for regulation of gene expression |
05/25/2001 | CA2391925A1 Antibodies |
05/25/2001 | CA2391906A1 Nucleic acid construct for optimized production of products |
05/25/2001 | CA2391885A1 Polypeptides and nucleic acids encoding same |
05/25/2001 | CA2391881A1 Transfer compounds, production and use thereof |
05/25/2001 | CA2391669A1 Mammalian genes: related reagents and methods |
05/25/2001 | CA2391593A1 Selectable cell surface marker genes |
05/25/2001 | CA2391569A1 Environmental stress tolerance genes |
05/25/2001 | CA2391560A1 The genome of the hiv-1 inter-subtype (c/b') and use thereof |
05/25/2001 | CA2391504A1 New olfactory receptor polypeptides and dna sequences thereof |
05/25/2001 | CA2391446A1 Plant biochemistry-related genes |
05/25/2001 | CA2391443A1 Plant developmental genes |
05/25/2001 | CA2391403A1 Novel protein and dna thereof |
05/25/2001 | CA2391399A1 Oleosins in cocoa |
05/25/2001 | CA2391380A1 Wnt-regulated cytokine-like polypeptide and nucleic acids encoding same |
05/25/2001 | CA2391212A1 Methods and compositions for identifying disease markers |
05/25/2001 | CA2391128A1 A method of making transgenic plants expressing a cecropin-hybrid cationic peptide imparting broad-spectrum pathogen resistance |
05/25/2001 | CA2391080A1 Erythropoietin forms with improved properties |
05/25/2001 | CA2390607A1 Materials and methods for detection and treatment of breast cancer |
05/25/2001 | CA2390600A1 Seed trait genes |
05/25/2001 | CA2390597A1 Pathogen tolerance genes |
05/25/2001 | CA2390594A1 Yield-related genes |
05/25/2001 | CA2390548A1 Ing2, an iaps associated cell cycle protein, compositions and methods of use |
05/25/2001 | CA2390547A1 Endogenous and non-endogenous versions of human g protein-coupled receptors |
05/25/2001 | CA2390292A1 Interferon gamma conjugates |
05/25/2001 | CA2390031A1 Double-stranded rna receptor (dsrna-r) and methods relating thereto |
05/25/2001 | CA2389662A1 Pentraxin i and pentraxin receptor, inhibitors of said proteins and pharmaceutical compositions containing said compounds |
05/25/2001 | CA2389566A1 Methods and compositions for treatment of disease |
05/25/2001 | CA2389430A1 Srik a novel cell cycle protein associated with rip3 |
05/25/2001 | CA2389289A1 Mammalian toxicological response markers |
05/25/2001 | CA2388922A1 23 human secreted proteins |
05/25/2001 | CA2388865A1 Novel g protein-coupled receptors |
05/25/2001 | CA2388777A1 18 human secreted proteins |
05/25/2001 | CA2386341A1 Heteroclitic analogs and related methods |
05/25/2001 | CA2385090A1 Cloning and characterization of the cap gene promoter |
05/25/2001 | CA2359758A1 Methods for conditional transgene expression and trait removal in plants |
05/24/2001 | US20010001710 Biologically pure culture of Bacillus thuringiensis strain PS50B having the identifying characteristics of NRRL B-21656; pesticides |
05/24/2001 | US20010001709 Methods for enhancing the production of viral vaccines in cell culture |
05/24/2001 | US20010001669 Compound delivery using rapidly dissolving collagen film |
05/24/2001 | US20010001661 Gene delivery in various muscle cell types; gene therapy for expression of erythropoietin to treat blood disorders such as anemias, for example |
05/23/2001 | EP1101820A1 Pentraxin I and Pentraxin receptor, inhibitors of said proteins and pharmaceutical compositions containing said compounds |
05/23/2001 | EP1101819A1 GENE Any-RF, DORMANCY REGULATORY SUBSTANCE, PROCESS FOR PRODUCING THE SAME AND CELL REGULATOR FOR VITAL CELLS |
05/23/2001 | EP1101771A1 Pathogen-induced genes from Capsicum annuum |
05/23/2001 | EP1101499A2 Diagnostic agents for pancreatic exocrine function |
05/23/2001 | EP1101112A2 Leptin-mediated gene-induction |
05/23/2001 | EP1100969A1 Methods and compositions for the determination of protein function and identification of modulators thereof |
05/23/2001 | EP1100962A1 Genetic polymorphisms in the human neurokinin 1 receptor gene and their uses in diagnosis and treatment of diseases |
05/23/2001 | EP1100960A1 Bivalent binding molecules of 7 transmembrane g protein-coupled receptors |
05/23/2001 | EP1100955A2 Agent and method for modulation of cell migration |
05/23/2001 | EP1100949A1 Fusion products containing insoluble proteinaceous tag |
05/23/2001 | EP1100944A1 Targeted alphavirus and alphaviral vectors |
05/23/2001 | EP1100941A2 Anti-angiogenesis plasmids and delivery systems, and methods of making and using the same |
05/23/2001 | EP1100940A2 Genes involved in tolerance to environmental stress |
05/23/2001 | EP1100934A1 Herpesvirus preparations and their uses |
05/23/2001 | EP1100926A1 TRIMER OF HIV $i(ENV) GENE EXPRESSION PRODUCT |
05/23/2001 | EP1100925A1 Attenuated equine herpesvirus |
05/23/2001 | EP1100924A1 Polynucleotide transporter protein |
05/23/2001 | EP1100923A2 Thermostable in vitro complex with polymerase activity |
05/23/2001 | EP1100922A1 Uses of the borreliacidal epitope(s) of borrelia burgdorferi outer surface protein c (ospc) as vaccine |
05/23/2001 | EP1100921A2 Streptococcus pneumoniae proteins and nucleic acid molecules |
05/23/2001 | EP1100920A2 Nucleic acids and proteins from group b streptococcus |
05/23/2001 | EP1100919A1 $i(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF |
05/23/2001 | EP1100918A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
05/23/2001 | EP1100917A1 Granulocytic ehrlichia genes and uses thereof |
05/23/2001 | EP1100915A2 Fibrous proteins and the production thereof |
05/23/2001 | EP1100914A2 Novel genes in control of hematopoiesis |
05/23/2001 | EP1100913A1 Mekk1 serine threonine kinases -interacting fha forkhead associated domain protein 1 (mif1) |
05/23/2001 | EP1100912A1 Method for screening of modulators of calcineurin activity |
05/23/2001 | EP1100911A1 Eukaryotic cell-based gene interaction cloning |
05/23/2001 | EP1100910A1 Dna encoding a human inhibitor-of-apoptosis protein; hiap3 |
05/23/2001 | EP1100909A2 Dna replication- and repair-associated proteins |
05/23/2001 | EP1100908A2 Human receptor-associated proteins |
05/23/2001 | EP1100907A2 Human cytoskeletal proteins |
05/23/2001 | EP1100906A1 Kdel receptor inhibitors |
05/23/2001 | EP1100905A2 Human epidermal proteins hepi-1 to hepi-6 |
05/23/2001 | EP1100904A2 Phosphorylation effectors |
05/23/2001 | EP1100903A1 Pb 39, a gene dysregulated in prostate cancer, and uses thereof |
05/23/2001 | EP1100902A1 Keratinocyte derived interferon |
05/23/2001 | EP1100901A1 Tumor associated antigen peptides and use of same as anti-tumor vaccines |
05/23/2001 | EP1100900A2 Xiap ires and uses thereof |
05/23/2001 | EP1100899A2 Delta-related polypeptides |
05/23/2001 | EP1100898A2 Human proteins having hydrophobic domains and dnas encoding these proteins |
05/23/2001 | EP1100897A2 Human proteins having hydrophobic domains and dnas encoding these proteins |
05/23/2001 | EP1100896A1 Dna encoding snorf33 receptor |
05/23/2001 | EP1100895A2 Abc1 polypeptide and methods and reagents for modulating cholesterol levels |
05/23/2001 | EP1100894A2 Short oligonucleotides for the inhibition of vegf expression |
05/23/2001 | EP1100893A1 Nucleic acids encoding proteins involved in sensory transduction |
05/23/2001 | EP1100890A2 Improved transformation efficiency in phage display through modification of a coat protein |
05/23/2001 | EP1100887A1 Growth differentiation factor-11 |
05/23/2001 | EP1100886A1 Tumor necrosis factor-gamma |
05/23/2001 | EP1100879A1 Pneumococcal nrdg protein |
05/23/2001 | EP1100877A1 Novel potassium channel molecules and uses therefor |
05/23/2001 | EP1100869A1 98 human secreted proteins |
05/23/2001 | EP1100830A2 Heterominibodies |
05/23/2001 | EP1100827A2 Peptides for the treatment, prophylaxis, diagnosis and monitoring of autoimmune diseases |
05/23/2001 | EP1100826A1 Isoforms of human calcium sensing receptor |
05/23/2001 | EP1100825A1 Human mink gene mutations associated with arrhythmia |
05/23/2001 | EP1100824A1 Compounds with growth hormone releasing properties |
05/23/2001 | EP1100823A2 Novel peptides for use in immunotherapy of autoimmune diseases |
05/23/2001 | EP1100822A1 Secreted cysteine rich protein-6 (scrp-6) |